Identification of whole blood gene expressions correlated with responsiveness to benralizumab - 04/02/21
![](/templates/common/images/mail.png)
This study was supported by a Grant-in-Aid for Scientific Research B (19H03663) from the Japan Society for the Promotion of Science and Clinical Research Support Program from the Japanese Society of Allergology. |
|
Disclosure of potential conflict of interest: N. Hizawa is on the GlaxoSmithKline advisory board; has received research support from Astellas, AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Kyorin, MSD, Novartis, and Chugai Pharmaceutical; and has received lecture fees from Astellas, AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Kyorin, MSD, and Novartis. The rest of the authors declare that they have no relevant conflicts of interest. |
Vol 147 - N° 2
P. 772-775 - Febbraio 2021 Ritorno al numeroBenvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?